Matthias Salathe is a Respiratory physician affiliated with University of Kansas Medical Center. OpenAlex indexes 260 publications with 8,954 citations (h-index 51); ClinicalTrials.gov lists 4 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4000 Cambridge St
Kansas City, KS 661608501
Telephone
913-588-1235Provider last certified this registry record 9 Apr 2026.
Clinical trials
- Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis.
Sponsor: University of Kansas Medical Center
- Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function
Sponsor: University of Kansas Medical Center
- Study of Open Label Losartan in COVID-19
Sponsor: University of Kansas Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Insmed, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
4 NIH research awards on record, funded 2018–2025 per NIH RePORTER. The latest:
- All of Us Research Program Heartland Consortium (AoURP-HC)
University of Kansas Medical Center
FY2025$1,500,000OT2OD036430 - All of Us Research Program Heartland Consortium (AoURP-HC)
University of Kansas Medical Center
FY2024$2,800,000OT2OD036430 - Mechanisms of mucociliary dysfunction in cystic fibrosis related diabetes
University of Kansas Medical Center
FY2024$660,756R01HL157942
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in cell culture and in mice
Proceedings of the National Academy of Sciences
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Mario Castro, MD
University of Kansas Medical Center
Jeffrey Burns, MD
University of Kansas Medical Center
Gary Gronseth, MD
University of Kansas Medical Center
Mazen Dimachkie, MD
University of Kansas Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”